REVANCE THERAPEUTICS LTD
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 2002-01-01
- Employees
- 597
- Market Cap
- $685.5M
- Website
- http://www.revance.com
Kirkland Advises Crown Laboratories on Amended Merger Agreement with Revance
Kirkland & Ellis advised Crown Laboratories on an amended merger agreement to acquire Revance Therapeutics for $3.10 per share. The deal, originally announced in August 2024, was revised due to Revance's breach notice from Teoxane, financial performance issues, and standalone company prospects. The transaction is expected to close in Q1 2025.
© Copyright 2024. All Rights Reserved by MedPath